fda bans tirzepatide 🚨 Attention: Your Voice Matters! 🚨, The is working to ban independent pharmacies from compounding effective weight-loss medications like Semaglutide (Ozempic) and (Mounjaro)—and we FDA says 'no clinical need'

The FDA approved semaglutide for diabetes sometime in 2010

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER "It is essential to understand the patient's complete medical and psychiatric history, including other medical conditions, precise weight change dynamics, concomitant medications and psychosocial stressors," he said

The study identified a higher number of patients with retained gastric contents in those undergoing EGD alone compared to no gastric contents in those undergoing combined EGD-colonoscopy ( It is unclear if the risks are lower with the combination of holding the medication and also having a bowel prep, if one of these approaches may be sufficient to reduce risks, or if even a clear liquid diet without a bowel prep could also be just as effective

Watch: USCs Steve Chen on the Future of Pharmacy and Value-Based Care To view or add a comment, sign in FDB on NCPDP Unscripted: Lathe Bigler explores price transparency, resilient e-prescribing, real-time benefits, empowering prescribers, patients, and adherence

Sun Pharma has got approval for two branded options, Sematrinity for type2 diabetes and Noveltreat for chronic weight management

While GLP-1 therapies may reduce long-term risks of cardiovascular disease, diabetes complications, and disability, those benefits often accrue over decadeswell beyond the timeframe relevant to most employer plan sponsors